Guillain–Barré syndrome

Definition

GBS is an acute immune-mediated polyradiculoneuropathy usually triggered by a recent infection. It causes progressive, symmetrical limb weakness, classically starting in the legs and ascending, with areflexia and risk of respiratory or autonomic involvement.

💡 It is the most common cause of acute flaccid paralysis in the UK.


Pathophysiology

  • Post-infectious autoimmune attack on peripheral nerves

  • Targets myelin (demyelinating form) or axons (axonal forms)

  • Leads to conduction block, weakness, and possible respiratory compromise

🚨 Severe inflammation may cause rapid progression to respiratory failure or sudden cardiac instability.


Risk factors and triggers

  • Recent Campylobacter jejuni gastroenteritis (most common)

  • Viral infections: CMV, EBV, HIV, influenza, COVID-19, Zika

  • Rarely after vaccination or surgery

  • More common in young adults and older age groups


Clinical features

  • Symmetrical weakness, starting distally and ascending

  • Areflexia (loss of tendon reflexes)

  • Paraesthesia or mild sensory symptoms

  • Facial weakness (often bilateral)

  • Back or limb pain

  • Autonomic dysfunction: fluctuating BP, arrhythmias, urinary retention

  • Respiratory involvement: reduced vital capacity, dyspnoea

🚨 Progression peaks within 4 weeks — close monitoring is essential.


Differentials

  • Cauda equina (asymmetrical, saddle anaesthesia)

  • Transverse myelitis (UMN signs, sensory level)

  • Myasthenia gravis (fluctuating weakness, reflexes preserved)

  • Botulism (descending paralysis, pupillary involvement)


Investigations (overview)

  • CSF: raised protein with normal WCC (albuminocytologic dissociation)

  • Nerve conduction studies: evidence of demyelination or axonal loss

  • Bedside: regular vital capacity checks, ECG and BP monitoring

  • Blood tests/serology: may support cause but not diagnostic

💡 Early nerve studies may be normal — repeat if suspicion remains high.


Management (principles)

  • Supportive care: airway and breathing monitoring, cardiac monitoring, VTE prophylaxis, nutrition and physio

  • Specific therapy: IV immunoglobulin (IVIG) or plasma exchange are effective if started within 2 weeks

  • ICU referral: if respiratory or autonomic compromise develops

🚨 Up to a third of patients require mechanical ventilation — early escalation is life-saving.


Complications

  • Respiratory failure

  • Autonomic instability (arrhythmias, BP swings)

  • Pressure sores, DVT

  • Long-term disability or fatigue


Prognosis

  • Most patients recover fully within 6–12 months

  • Severe cases may leave residual weakness

  • Mortality around 5%, usually due to respiratory or autonomic complications


Ready to take your revision to the next level?

This is only a small part of our full Medifries textbook.
Sign up today to access:
- 100% UK-guideline aligned notes for every UKMLA topic
- Thousands of high-quality SBA questions
- Anki-integrated flashcards for active recall
- Clinical cases, diagrams, and personalised study tools
👉 Create your free account now